Muscular Dystrophy (MD) is a group of genetic disorders. It causes progressive muscle weakness and degeneration. It progressively affects a person’s mobility, posture, breathing, and heart functionality over time. Specialized care, along with timely intervention, greatly helps in managing the symptoms and improving the overall quality of life.
Bangalore is a leading medical hub in South India. The city offers world-class treatment options for muscular dystrophy. With top neurology centers and rehabilitation facilities, along with world-class Muscular Dystrophy treatments in Bangalore, patients have access to therapies from around the world that are clinically approved.
What Is Muscular Dystrophy?
Muscular dystrophy is mainly caused by mutations in genes responsible for muscle structure and function. It is progressive and complex, but many treatments help delay complications, improve muscle strength, and increase daily living.
Common Types of Muscular Dystrophy:
Duchenne Muscular Dystrophy (DMD) – Most common in children (mostly boys)
Becker Muscular Dystrophy (BMD) – Slower progression than DMD
Facioscapulohumeral Dystrophy (FSHD)
Limb-Girdle Muscular Dystrophy (LGMD)
Myotonic Dystrophy
Emery-Dreifuss Muscular Dystrophy
Why Bangalore for Muscular Dystrophy Treatment?
Bangalore is home to some of India’s most advanced neurology and genetics centers, offering cutting-edge diagnostics, FDA-approved medicines, physical rehabilitation, and even clinical trial access.
Here’s why patients from across South India—including Tamil Nadu, Andhra Pradesh, Telangana, and Kerala—choose Bangalore:
- Advanced genetic testing labs
- Multispecialty hospitals with experienced neurologists
- Availability of global treatments via Named Patient Programs (NPP)
- Rehabilitation centers with physiotherapy, speech therapy & occupational therapy
- Pediatric neuromuscular care units
FDA-Approved & Investigational Medicines for Muscular Dystrophy:
Recent FDA-approved medicines have made a major difference in the management and treatment of this condition.
Viltepso (viltolarsen):
This medicine is approved for Duchenne Muscular Dystrophy (DMD) patients with a confirmed mutation amenable to exon 53 skipping.
Exondys 51 (eteplirsen):
This therapeutic drug treats cases of Duchenne Muscular Dystrophy (DMD) for patients who have a genetic mutation suitable for exon 51 skipping. It also helps improve the production of dystrophin.
Vyondys 53 (golodirsen):
It is another therapeutic drug capable of exon skipping. Vyondys 53 (golodirsen) is approved for patients with exon 53 mutations.
Amondys 45 (casimersen):
This medicinal product is designed to treat patients with an exon 45 mutation in Duchenne Muscular Dystrophy (DMD). These medicines support the production of functional dystrophin.
Emflaza (deflazacort):
A corticosteroid medication, which is used to control inflammation and preserve muscle strength in patients with Duchenne Muscular Dystrophy (DMD) is Emflaza (deflazacort). Patients eligible must be 2 years old and above.
Elevidys (delandistrogene moxeparvovec-rokl):
This recently FDA-approved gene therapy is for young children with Duchenne Muscular Dystrophy (DMD) and certain mutations. It places a mini-dystrophin gene to enable the restoration of muscle function.
These therapeutic drugs are unavailable in India but can be imported upon request. These can be accessed in India through Named Patient Programs (NPP)—a legal framework that allows importation of unapproved medicines for individual patient use under medical supervision.
How Indian Pharma Network (IPN) Helps South India Patients?
In case any medicine is unavailable in India, Indian Pharma Network (IPN) can help patients and doctors access it safely and through legal channels.
What We Offer:
- Global sourcing of FDA-approved Duchenne Muscular Dystrophy (DMD) medicines
- CDSCO-compliant Named Patient Import support
- Cold chain handling for gene therapy and biologics
- Delivery to patients across Bangalore, Kochi, Chennai, Hyderabad, and other cities
- Coordination with healthcare professionals (HCPs), hospitals, and caregivers
Comprehensive Care in Bangalore:
The management of muscular dystrophy is not solely medication-focused; it involves a sustained multidisciplinary approach. The best hospitals in Bangalore provide:
- Genetic Testing & Counseling
- Neurology & Pediatric Neurology Consultations
- Physiotherapy, Hydrotherapy, Occupational & Speech Therapy
- Dietary & Respiratory Support
- Assistive Devices & Orthotic Support
These services are available in institutions like NIMHANS, Manipal Hospital, Aster CMI Hospital, Fortis Hospital, People Tree Hospitals, Vydehi Institute of Medical Sciences and Research Centre, Apollo Hospitals, BGS Gleneagles Global Hospital, and Rainbow Children’s Hospital, which are well-known for their neuromuscular care programs.
Need Help Accessing Medicines Like Viltepso, Exondys 51, or Elevidys?
Indian Pharma Network (IPN) can assist patients, Hospitals, families, and doctors across South India to get safe, legal access to life-saving medicines for muscular dystrophy (MD). We work closely with neurologists and hospitals to import genuine medicines from Trusted manufacturers across the world. Contact us today to request an unavailable medicine.
Disclaimer: This blog is for informational purposes only. Please consult your neurologist before beginning any treatment. IPN does not promote or advertise any unapproved medicines but facilitates legal access based on patient need and doctor’s prescription.
Where can I get treatment for Duchenne Muscular Dystrophy in Bangalore?
You may visit NIMHANS, Fortis Hospital, Manipal Hospital, and Apollo Hospitals. Their Neurology departments provide complete multidisciplinary services and provide patients access to hard-to-find specialty medicines through legal importation.
Are there FDA-approved medicines for muscular dystrophy available in India?
Yes, hard-to-access medicines like Viltepso, Exondys 51, and Emflaza can be accessed in India under the Named Patient Program (NPP). A trusted importer like Indian Pharma Network (IPN) is a leading name in the NPP segment.
What kind of therapy is recommended along with medication?
Medications offer greater success with physiotherapy, respiratory care, speech therapy, and occupational therapy, which work to maximize mobility and enhance overall quality of life.
How do I access Exondys 51 or Viltepso from India?
You will need a valid prescription from a treating doctor. Indian Pharma Network (IPN) will guide you through the compliant import process and arrange safe delivery.
Is genetic testing available in Bangalore for muscular dystrophy?
Yes, a plethora of diagnostic labs and neurology centers in Bangalore offer advanced genetic testing as well as mutation analysis for these conditions.
Which hospitals in Bangalore does Indian Pharma Network help in accessing DMD medicines?
Indian Pharma Network (IPN) collaborates with leading hospitals and neurology centers in Bangalore to help patients access FDA-approved Duchenne Muscular Dystrophy medicines such as Exondys 51, Viltepso, Amondys 45, and Emflaza. These drugs, though not yet widely available in India, can be imported through legal Named Patient Import pathways with proper medical prescriptions.
IPN supports the following top hospitals in Bangalore:
Aster CMI Hospital, Hebbal
St. John’s Medical College Hospital
Apollo Hospitals (Bannerghatta Road & Jayanagar)
BGS Gleneagles Global Hospital
Fortis Hospitals (Cunningham Road & Bannerghatta Road)
Rainbow Children’s Hospital, Marathahalli
Columbia Asia Hospital, Yeshwanthpur
Sakra World Hospital
NIMHANS (National Institute of Mental Health and Neurosciences),
Manipal Hospital (Old Airport Road & Whitefield)
